Nieuwsfeed
- AstraZeneca trial shows modest benefit in ovarian cancer, but doctors say it's hard to apply findings to patients
- Gilead, Arcus’ updated TIGIT data unlikely to resolve debates around space: #ASCO23
- Uitgelicht en gespot op internet (week 22, 2023)
- Perioperative Keytruda improves event-free survival in early NSCLC: #ASCO23
- Weekend reads: How university rankings lead to bad science; how to report research misconduct; the impact of Retraction Watch reporting
- Roger Perlmutter lines up deals, fresh funding at Eikon; Second RSV vaccine approved; Several biotechs flashing red; and more
- Poor effort on cognitive testing in voluntary research predicts failure in US Army Ranger School: Implications for clinical trial design
- Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials
- Partner engagement for planning and development of non-pharmacological care pathways in the AIM-Back trial
- The improving Medication Adherence in Adolescents and young adults following Liver Transplantation (iMALT) multisite trial: Design and trial implementation considerations
- User Fee Lists
- Biologics PREA Reviews and Labeling Changes
- Biologics Electronic Reading Room (eFOI)
- FDA CDER & NIH NCATS Regulatory Fitness in Rare Disease Clinical Trials Workshop - 05/16/2022
- PREVNAR 20
- FDA Roundup: June 2, 2023
- Withdrawn/Expired Guidances (Drugs)
- Grail presents results of blood test study in patients suspected of cancer: #ASCO23
- AtomVie raises $66M+ for new Ontario manufacturing site
- GDUFA Type II API DMF Payment Receipts Report
- NICE recommends Bristol Myers' heart drug Camzyos in UK
- GSK campaign promotes routine vaccinations for adults in 'critical moment for public health'
- Gilead joins TikTok with oncology awareness campaign featuring diverse group of cancer advocates
- Clinical Guidances
- Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals
- Novo Nordisk wins in age bias suit with the Equal Employment Opportunity Commission
- We Are Hiring
- 3M doubles down on biotech manufacturing materials with $146M investment
- Frequently requested or proactively posted compliance records
- Vaccines and Related Biological Products Advisory Committee May 18, 2023 Meeting Announcement - 05/18/2023
- Cellular, Tissue, and Gene Therapies Advisory Committee May 12, 2023 Meeting Announcement - 05/12/2023
- We Have Met the Enemy and It Is Us
- First patient enrolled in pulmonary hypertension reduction device study
- Division of Applied Regulatory Science
- Insolvenzverfahren : Geld gegen Aussonderungsrechte – Vergleichsangebot für AvP-Apotheken
- FDA updates on hand sanitizers consumers should not use
- Dollars flow with three new public offerings, two private placements
- Illumina names Hologic CEO as new board member and chair
- Compounding: Inspections, Recalls, and other Actions
- Ziekenhuizen bezorgd over commerciële detacheerders
- Honderd patiënten met corona in ziekenhuizen
- Grußwort in Düsseldorf: Lauterbach kommt wieder nur digital zum DAT
- ‘Blockbuster’ menopause drug approved
- German zoos join Transparency Agreement
- Innovent and Merck to carry out cancer combination therapy trial
- Insights into hibernation using animals
- Brain implant treats paralysed man
- Quality Metrics for Drug Manufacturing
- News from ETP
- CDER Quality Management Maturity
Op de hoogte blijven van actueel nieuws, bijeenkomsten en publieke consultaties